Koyfin Home > Directory > Health Care > Accelerate Diagnosti > Repurchase of Common Stock

Accelerate Diagnosti Repurchase of Common Stock Chart (AXDX)

Accelerate Diagnosti annual/quarterly Repurchase of Common Stock from 2012 to 2018.
  • Accelerate Diagnosti Repurchase of Common Stock for the quarter ending December 12, 2018 was $0m a 0.00% increase of 45m year over year
  • Accelerate Diagnosti Repurchase of Common Stock for the last 12 months ending September 09, 2019 was $0m a 0.00% increase of 45m year over year
Other Cash Flow Metrics:
  • Accelerate Diagnosti Cash Flow from Operations for the quarter ending December 12, 2018 was $-14m a -12.16% increase of 2m year over year
  • Accelerate Diagnosti Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-21m a 52.31% decrease of -11m year over year
  • Accelerate Diagnosti Total Revenue for the quarter ending September 09, 2018 was $1m a -56.38% decrease of -1m year over year
View Chart On Koyfin

Quarterly AXDX Repurchase of Common Stock Data

12/2018$0m
09/2018$0m
06/2018$0m
03/2018$-45m
09/2014$0m
12/2012$-14m

Annual AXDX Repurchase of Common Stock Data

2018$-45m